[Adjuvant after care of the "small" ovarian cancer (FIGO I): chemotherapy versus radiogold treatment].
Kaesemann
H
H
Universitäts-Frauenklinik, Würzburg.
Caffier
H
H
Rotte
K
K
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D005500:Follow-Up Studies; D006050:Gold Radioisotopes / Q000627:therapeutic use; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy* / Q000601:surgery; D015996:Survival Rate
D006050:Gold Radioisotopes; D003520:Cyclophosphamide; D005472:Fluorouracil
Adjuvante Nachbehandlung des "kleinen" Ovarialkarzinoms (FIGO I): Chemotherapie versus Radiogoldbehandlung.